Skip to main content
Clinical Trials/NCT04641988
NCT04641988
Completed
Not Applicable

Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19) : COROBIOCHIC

University Hospital, Montpellier1 site in 1 country111 target enrollmentFebruary 1, 2020
ConditionsCOVID-19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19
Sponsor
University Hospital, Montpellier
Enrollment
111
Locations
1
Primary Endpoint
hs-cTnT
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Objective: To assess the prognostic value of high-sensitive cardiac troponin T (hs-cTnT) and N-terminal pro brain natriuretic peptide (NT-proBNP) at ICU admission in patients with coronavirus disease 2019 (COVID-19).

Design: Multicenter retrospective observational cohort study Setting: Three ICUs at three hospitals in Occitanie, France. Patients: Adults (≥ 18 years old) with laboratory-confirmed COVID-19 and at least one hs-cTnT measurement at ICU admission, from March 9, 2020, to May 9, 2020.

Registry
clinicaltrials.gov
Start Date
February 1, 2020
End Date
June 30, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

hs-cTnT

Time Frame: at ICU admission

hs-cTnT

Secondary Outcomes

  • NT-proBNP(at ICU admission)

Study Sites (1)

Loading locations...

Similar Trials